Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland.
Pediatrics. 2011 Jun;127(6):e1445-8. doi: 10.1542/peds.2010-3756. Epub 2011 May 2.
Although a history of previous acute mountain sickness (AMS) is commonly used for providing advice and recommending its prophylaxis during subsequent exposure, the intraindividual reproducibility of AMS during repeated high-altitude exposure has never been examined in a prospective controlled study.
In 27 nonacclimatized children and 29 adults, AMS was assessed during the first 48 hours after rapid ascent to 3450 m on 2 consecutive occasions 9 to 12 months apart.
During the first exposure, 18 adults (62%) and 6 children (22%) suffered from AMS; during the second exposure, 14 adults (48%) and 4 children (15%) suffered from this problem (adults versus children, P ≤ .01). Most importantly, the intraindividual reproducibility of AMS was very different (P < .001) between children and adults. None of the 6 children having suffered from AMS during the first exposure suffered from AMS during the second exposure, but 4 children with no AMS during the first exposure did experience this problem during the second exposure. In contrast, 14 of the 18 adults who suffered from AMS on the first occasion also presented with this problem during the second exposure, and no new case developed in those who had not experienced AMS on the first occasion.
In adults, a history of AMS is highly predictable of the disease on subsequent exposure, whereas in children it has no predictive value. A history of AMS should not prompt practitioners to advise against reexposure to high altitude or to prescribe drugs for its prophylaxis in children.
尽管先前有过急性高山病(AMS)病史通常被用于在随后的高海拔暴露期间提供建议并推荐其预防措施,但在前瞻性对照研究中,从未检查过在反复高海拔暴露期间 AMS 的个体内重现性。
在 27 名未适应的儿童和 29 名成年人中,在连续两次快速上升到 3450 米后,在 48 小时内评估 AMS。两次暴露之间相隔 9 至 12 个月。
在第一次暴露期间,18 名成年人(62%)和 6 名儿童(22%)患有 AMS;在第二次暴露期间,14 名成年人(48%)和 4 名儿童(15%)患有此问题(成年人与儿童相比,P ≤.01)。最重要的是,AMS 的个体内重现性在儿童和成人之间差异非常大(P <.001)。在第一次暴露期间患有 AMS 的 6 名儿童中,没有一名在第二次暴露期间患有 AMS,但在第一次暴露期间没有 AMS 的 4 名儿童在第二次暴露期间患有 AMS。相比之下,在第一次发作时患有 AMS 的 18 名成年人中有 14 人在第二次发作时也出现了这种问题,而在第一次发作时没有经历过 AMS 的人则没有新的病例出现。
在成年人中,AMS 的病史对随后的暴露高度可预测疾病,而在儿童中则没有预测价值。在儿童中,AMS 的病史不应促使医生建议避免重新暴露于高海拔地区或开预防药物。